中性粒细胞表型的床旁分析:创伤ICU免疫精准医学的第一步
本研究为在1级创伤中心开展的前瞻性队列研究,纳入所有进入创伤抢救室的创伤患者,在抢救室内由创伤团队成员将额外采血管放入全自动流式细胞仪,自动执行改良方案。164例中156例成功启动床旁分析,成功率为95%。发生感染并发症的多发伤患者CD16dim/CD62Lbright中性粒细胞百分比显著高于未发生者(p=0.002),曲线下面积为0.90(0.83-0.97)。作者认为该检测可用于早期识别有感染并发症风险的患者,并作为ICU多发伤患者免疫精准医学的第一步。
要点
- 创伤团队在抢救室床旁启动全自动流式细胞术分析,164例中成功156例,成功率为95%。
- 发生感染并发症的多发伤患者CD16dim/CD62Lbright中性粒细胞百分比显著高于未发生感染并发症者(p=0.002)。
- %CD16dim/CD62Lbright中性粒细胞的曲线下面积为0.90(0.83-0.97),作者认为可用于早期识别感染并发症风险。
- 作者认为该床旁检测可作为ICU多发伤患者免疫精准医学的第一步。
适用人群与场景
- 所有进入创伤抢救室的创伤患者被纳入本研究。
- 分析比较了发生感染并发症的多发伤患者与未发生感染并发症的多发伤患者。
处置流程与药物剂量
- 从所有患者额外采集一管血,由创伤团队成员将采血管放入位于创伤抢救室角落的全自动流式细胞仪,自动执行本研究改良定制的方案。
研究设计与关键结果
- 研究设计为前瞻性队列研究,在1级创伤中心开展,比较发生与未发生感染并发症的多发伤患者。
- 创伤团队在164例患者中成功启动床旁全自动流式细胞术分析156例,成功率为95%。
- 发生感染并发症的多发伤患者CD16dim/CD62Lbright中性粒细胞百分比显著高于未发生感染并发症者(p=0.002)。
- %CD16dim/CD62Lbright中性粒细胞的曲线下面积为0.90(0.83-0.97)。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,CD16dim/CD62Lbright中性粒细胞的评估可用于早期识别有感染并发症风险的患者。
- 作者认为,该床旁检测可作为ICU多发伤患者免疫精准医学的第一步。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The amount of tissue damage and the amplitude of the immune response after trauma are related to the development of infectious complications later on. Changes in the neutrophil compartment can be used as read out of the amplitude of the immune response after trauma. The study aim was to test whether 24/7 point-of-care analysis of neutrophil marker expression by automated flow cytometry can be achieved after trauma.
DESIGN: A prospective cohort study was performed. Polytrauma patients who developed infectious complications were compared with polytrauma patients who did not develop infectious complications.
SETTING: The study was performed in a level 1 trauma center.
PATIENTS: All trauma patients presented in the trauma bay were included.
INTERVENTIONS: An extra blood tube was drawn from all patients. Thereafter, a member of the trauma team placed the blood tube in the fully automated flow cytometer, which was located in the corner of the trauma room. Next, a modified and tailored protocol for this study was automatically performed.
MAIN RESULTS: The trauma team was able to successfully start the point-of-care automated flow cytometry analysis in 156 of 164 patients, resulting in a 95% success rate. Polytrauma patients who developed infectious complications had a significantly higher %CD16dim/CD62Lbright neutrophils compared with polytrauma patients who did not develop infectious complications (p = 0.002). Area under the curve value for %CD16dim/CD62Lbright neutrophils is 0.90 (0.83-0.97).
CONCLUSIONS: This study showed the feasibility of the implementation of a fully automated point-of-care flow cytometry system for the characterization of the cellular innate immune response in trauma patients. This study supports the concept that the assessment of CD16dim/CD62Lbright neutrophils can be used for early detection of patients at risk for infectious complications. Furthermore, this can be used as first step toward immuno-based precision medicine of polytrauma patients at the ICU.
参考来源
- Spijkerman R, Hesselink L, Bongers S, et al. Point-of-Care Analysis of Neutrophil Phenotypes: A First Step Toward Immuno-Based Precision Medicine in the Trauma ICU. Crit Care Explor. 2020. PMID: 32766555. doi:10.1097/CCE.0000000000000158
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。